Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 8Thoracic 3Gastrointestinal 2Breast 2Sarcoma 1Other solid neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Uterine Cervical Neoplasms 10Ovarian Neoplasms 5Endometrial Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Pancreatic Neoplasms 3Melanoma 3Carcinoma, Renal Cell 3Neoplasm Metastasis 2Mesothelioma 2Esophageal Neoplasms 2Cholangiocarcinoma 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Anus Neoplasms 2Uveal Melanoma 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Pelvic Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms 1Lung Neoplasms 1Hemangiosarcoma 1Head and Neck Neoplasms 1Glioblastoma 1

Interventions

Paclitaxel 28Carboplatin 28pembrolizumab 25Bevacizumab 14liposomal doxorubicin 12Cisplatin 11Gemcitabine 10Radiotherapy 8Drug Therapy 8Cyclophosphamide 8Blood Specimen Collection 8Topotecan 7Nivolumab 7olaparib 6Doxorubicin 6niraparib 5Therapeutics 5Dexamethasone 5pertuzumab 4pazopanib 4lenvatinib 4fludarabine 4cemiplimab 4atezolizumab 4Trastuzumab 4Surveys and Questionnaires 4Psychiatric Rehabilitation 4Polymerase Chain Reaction 4Fulvestrant 4Docetaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × spartalizumab × Gynecologic × Clear all
NCT03757858 2024-02-07

Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases

Capital Medical University

Phase 1/2 Completed
40 enrolled
Gynecologic

Neoplasm Metastasis, Neoplasms, Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡